Annual Accounts Payable
$5.90 M
-$7.99 M-57.54%
31 December 2023
Summary:
Allogene Therapeutics annual accounts payable is currently $5.90 million, with the most recent change of -$7.99 million (-57.54%) on 31 December 2023. During the last 3 years, it has fallen by -$4.49 million (-43.24%). ALLO annual accounts payable is now -57.54% below its all-time high of $13.89 million, reached on 31 December 2022.ALLO Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$5.51 M
-$7.43 M-57.44%
30 September 2024
Summary:
Allogene Therapeutics quarterly accounts payable is currently $5.51 million, with the most recent change of -$7.43 million (-57.44%) on 30 September 2024. Over the past year, it has dropped by -$699.00 thousand (-11.27%). ALLO quarterly accounts payable is now -76.57% below its all-time high of $23.50 million, reached on 30 June 2019.ALLO Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ALLO Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -57.5% | -11.3% |
| 3 y3 years | -43.2% | -52.1% |
| 5 y5 years | -52.2% | -31.6% |
ALLO Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -57.5% | at low | -62.5% | at low |
| 5 y | 5 years | -57.5% | at low | -63.0% | at low |
| alltime | all time | -57.5% | -76.6% | +334.2% |
Allogene Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $5.51 M(-57.4%) |
| June 2024 | - | $12.94 M(+123.8%) |
| Mar 2024 | - | $5.78 M(-2.0%) |
| Dec 2023 | $5.90 M(-57.5%) | $5.90 M(-5.0%) |
| Sept 2023 | - | $6.21 M(-39.3%) |
| June 2023 | - | $10.23 M(-30.4%) |
| Mar 2023 | - | $14.69 M(+5.7%) |
| Dec 2022 | $13.89 M(+35.4%) | $13.89 M(+25.8%) |
| Sept 2022 | - | $11.04 M(+13.7%) |
| June 2022 | - | $9.71 M(+11.5%) |
| Mar 2022 | - | $8.71 M(-15.1%) |
| Dec 2021 | $10.26 M | $10.26 M(-10.8%) |
| Sept 2021 | - | $11.50 M(+4.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2021 | - | $11.01 M(-26.0%) |
| Mar 2021 | - | $14.88 M(+43.2%) |
| Dec 2020 | $10.39 M(+12.3%) | $10.39 M(+2.4%) |
| Sept 2020 | - | $10.15 M(+12.1%) |
| June 2020 | - | $9.06 M(+25.8%) |
| Mar 2020 | - | $7.20 M(-22.2%) |
| Dec 2019 | $9.25 M(-25.0%) | $9.25 M(+14.9%) |
| Sept 2019 | - | $8.05 M(-65.8%) |
| June 2019 | - | $23.50 M(+81.1%) |
| Mar 2019 | - | $12.98 M(+5.2%) |
| Dec 2018 | $12.34 M(>+9900.0%) | $12.34 M(+300.2%) |
| Sept 2018 | - | $3.08 M(+143.1%) |
| June 2018 | - | $1.27 M |
| Dec 2017 | $0.00 | - |
FAQ
- What is Allogene Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Allogene Therapeutics?
- What is Allogene Therapeutics annual accounts payable year-on-year change?
- What is Allogene Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Allogene Therapeutics?
- What is Allogene Therapeutics quarterly accounts payable year-on-year change?
What is Allogene Therapeutics annual accounts payable?
The current annual accounts payable of ALLO is $5.90 M
What is the all time high annual accounts payable for Allogene Therapeutics?
Allogene Therapeutics all-time high annual accounts payable is $13.89 M
What is Allogene Therapeutics annual accounts payable year-on-year change?
Over the past year, ALLO annual accounts payable has changed by -$7.99 M (-57.54%)
What is Allogene Therapeutics quarterly accounts payable?
The current quarterly accounts payable of ALLO is $5.51 M
What is the all time high quarterly accounts payable for Allogene Therapeutics?
Allogene Therapeutics all-time high quarterly accounts payable is $23.50 M
What is Allogene Therapeutics quarterly accounts payable year-on-year change?
Over the past year, ALLO quarterly accounts payable has changed by -$699.00 K (-11.27%)